Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Report of specific cardiovascular outcomes of the ADVANTAGE trial.

    Egilman DS, Presler AH.

    Ann Intern Med. 2006 May 16;144(10):781. No abstract available. Erratum in: Ann Intern Med. 2006 Jun 20;144(12):943. PMID: 16702599 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Stopping a trial early in oncology: for patients or for industry?

    Bradbury P, Meyer R, Pater J, Tu D, Seymour L, Shepherd L, Eisenhauer E.

    Ann Oncol. 2009 Feb;20(2):395-6. Epub 2009 Jan 15. No abstract available. PMID: 19150952 [PubMed - indexed for MEDLINE]Related articles

    3.

    Ethics. Clinical trials guidelines at odds with U.S. policy.

    Normile D.

    Science. 2008 Oct 24;322(5901):516. No abstract available. PMID: 18948510 [PubMed - indexed for MEDLINE]Related articles

    4.

    Institution/investigator-initiated clinical trials in Canada.

    Sedgeworth J, Derewlany L.

    Can J Clin Pharmacol. 2006 Summer;13(2):e236-9. Epub 2006 Jul 25.PMID: 16873897 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A randomized controlled trial of auricular acupuncture for cocaine dependence: treatments vs outcomes.

    Giglio JC.

    Arch Intern Med. 2001 Mar 26;161(6):894-5; author reply 895. No abstract available. PMID: 11268238 [PubMed - indexed for MEDLINE]Related articles

    6.

    Stopping a trial early in oncology: for patients or for industry?

    Whitehead J, Cobo E.

    Ann Oncol. 2008 Aug;19(8):1512-3. Epub 2008 Jul 10. No abstract available. PMID: 18621741 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    How confidential trial negotiations and agreements between the Food and Drug Administration and sponsors marginalize local institutional review boards, and what to do about it.

    Mann H.

    Am J Bioeth. 2006 May-Jun;6(3):22-4; discussion W49-50. No abstract available. PMID: 16754442 [PubMed - indexed for MEDLINE]Related articles

    8.

    Integrity of scientific data: transparency of clinical trial data.

    Moore N, Juillet Y, Bertoye PH; Round Table No 4, Giens XXII.

    Therapie. 2007 May-Jun;62(3):203-9, 211-6. Epub 2007 Sep 6. Review. English, French. PMID: 17803887 [PubMed - indexed for MEDLINE]Related articles

    9.

    Issues pertaining to the critiques of the SAINT-I Trial.

    Fisher M, Hess DC, Lees K.

    Stroke. 2007 Nov;38(11):e126-7; author reply e128. No abstract available. PMID: 17968005 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The published randomized controlled trial (RCT) of fetal heart rate monitoring by Vintzileos et al.

    Schifrin BS.

    Birth. 1994 Dec;21(4):236-7. No abstract available. PMID: 7857473 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical trials, outcomes, and statistics: how better can be worse.

    Riggs JE, Hobbs GR.

    Neurology. 1998 Oct;51(4):1234-5. No abstract available. PMID: 9781583 [PubMed - indexed for MEDLINE]Related articles

    12.

    Industry-sponsored clinical research: a broken system.

    Angell M.

    JAMA. 2008 Sep 3;300(9):1069-71. No abstract available. PMID: 18768418 [PubMed - indexed for MEDLINE]Related articles

    13.

    Critical lessons from the ENHANCE trial.

    Greenland P, Lloyd-Jones D.

    JAMA. 2008 Feb 27;299(8):953-5. No abstract available. PMID: 18314439 [PubMed - indexed for MEDLINE]Related articles

    14.

    The corrected values for duration and frequency of angina at baseline in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial.

    Boden WE, O'Rourke RA, Teo KK, Weintraub WS.

    Am J Cardiol. 2007 Nov 15;100(10):1604. No abstract available. PMID: 18051252 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reporting of drug tolerance in randomized clinical trials: when data conflict with authors' conclusions.

    Jonville-Béra AP, Giraudeau B, Autret-Leca E.

    Ann Intern Med. 2006 Feb 21;144(4):306-7. No abstract available. PMID: 16490923 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Canadian Association for Immunization Research and Evaluation (CAIRE) guidelines for industry-sponsored clinical trial and epidemiology contract research.

    Halperin SA, Scheifele D, Duval B, Law B, Ward B, Bjornson G, Halperin B, Skowronski D, King A, Hammond G, Dobson S, Tamblyn S, Wang E, Lavigne P, Danzig L, Elrick D, Carnan E, Mansi J, Bertrand F, Palkonyay L, Clements G, Maresky N, Wortzman D; Canadian Association for Immunization Research and Evaluation (CAIRE).

    Hum Vaccin. 2005 Jul-Aug;1(4):140-2. Epub 2005 Jul 30.PMID: 17012864 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Randomized control trial of immunosuppression in paraquat poisoning.

    Gunawardena G, Roberts DM, Buckley NA.

    Crit Care Med. 2007 Jan;35(1):330-1; author reply 331. No abstract available. PMID: 17197797 [PubMed - indexed for MEDLINE]Related articles

    18.

    Understanding clinical trial outcomes: design, analysis, and interpretation.

    Jacobe HT, Leitenberger JJ, Bergstresser PR.

    Dermatol Ther. 2007 Mar-Apr;20(2):77-85.PMID: 17537135 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impugning the integrity of medical science: the adverse effects of industry influence.

    DeAngelis CD, Fontanarosa PB.

    JAMA. 2008 Apr 16;299(15):1833-5. No abstract available. PMID: 18413880 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data